1-18 of 18
Keywords: mortality
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Clin Sci (Lond) (2018) 132 (5): 509–522.
Published: 09 March 2018
... immune system, adipocyte dysfunction with insulin resistance, and low turnover bone disease. Higher blood levels of gut-derived uremic toxins are associated with increased cardiovascular events and mortality in the CKD population. Clinical trials that have examined interventions to trap toxic products...
Articles
Clin Sci (Lond) (2013) 124 (4): 255–257.
Published: 05 November 2012
... studies supporting the hypothesis that UA independently influences cardiovascular disease outcomes and mortality, a causal role is yet to be established. Serum UA is also considered as a useful biomarker for mortality in high-risk patients with acute coronary syndromes, heart failure and hypertension...
Articles
Clin Sci (Lond) (2013) 124 (4): 259–268.
Published: 05 November 2012
... outcome was 1-year all-cause mortality. The UA concentration [median (25th–75th quartiles)] was 6.44 mg/dl (5.40–7.70 mg/dl). There were 264 deaths (7.1%) during follow-up: 45 deaths in patients of the first UA quartile, 43 deaths in patients of the second UA quartile, 51 deaths in patients of the third...
Articles
Clin Sci (Lond) (2012) 122 (12): 591–597.
Published: 05 March 2012
...Paul Castillo Rodas; Olav Rooyackers; Christina Hebert; Åke Norberg; Jan Wernerman Glutamine depletion is demonstrated to be an independent predictor of hospital mortality in ICU (intensive care unit) patients. Today glutamine supplementation is recommended to ICU patients on parenteral nutrition...
Articles
Clin Sci (Lond) (2010) 119 (12): 515–517.
Published: 01 September 2010
... the modulation of ACTH and IL-10 to the effect of this peptide is indirect, because it is based on neutralization of the putative offender. Direct proof of the toxicity of N-ProCT would entail administering this peptide to LPS-treated rats and observing an augmented mortality. Although this important paper...
Articles
Articles
Articles
Clin Sci (Lond) (2010) 118 (3): 183–185.
Published: 26 October 2009
.... In the present issue of Clinical Science , Zhang and co-workers prove that Chinese patients with high homocysteine levels have an increased risk of stroke recurrence and of all-cause mortality with respect to patients with lower levels. Remarkably, in their study, high homocysteine levels were associated...
Articles
Articles
Articles
Articles
Clin Sci (Lond) (2007) 113 (3): 119–127.
Published: 02 July 2007
...Jennifer H. Martin; Henry Krum HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitors (statins) are well-established therapies in the prevention and treatment of cardiovascular disease, reducing all-cause mortality and cardiovascular events in many disease states. Studies have also suggested...
Articles
Clin Sci (Lond) (2005) 109 (1): 75–82.
Published: 23 June 2005
...Susan J. CARR; Sunita BAVANANDAN; Barbara FENTUM; Leong NG In the present study, we investigated the potential of N-BNP (N-terminal B-type natriuretic peptide) as a prognostic marker for risk of CV (cardiovascular) events, overall mortality and progression to ESRD (end-stage renal disease...
Articles
Clin Sci (Lond) (2002) 103 (5): 511–515.
Published: 23 October 2002
...Martin TEPEL; Markus VAN DER GIET; Alexander PARK; Walter ZIDEK Patients with end-stage renal disease show disturbances of calcium metabolism, including calcification of arterial walls. Such patients show increased mortality, in particular due to increased cardiovascular-associated deaths...
Articles
Clin Sci Mol Med (1976) 51 (s3): 645s–647s.
Published: 01 December 1976
...-hypertensive agents cerebrovascular disorders coronary disease hypertension morbidity mortality Clinical Science and Molecular Medicine (1976) 51,645s-647~. Report on progress in the Australian National Blood Pressure Study (NBPS) J. D. A B E R N E T H Y , J . L. B A K E R , M. U . B U L L E N , M . L...
Articles
Clin Sci Mol Med (1976) 51 (s3): 649s–651s.
Published: 01 December 1976
... hypertension mortality Clinical Science and Molecular Medicine (1976) 51, 649s-651s. Characteristics and prognosis for women with hypertension in a community: results of a longitudinal study in Goteborg, Sweden c. BENGTSSON A N D 0. L I N D Q U I S T Drpnrtnirnt Medicine, I I , Snhlgrcvi's Hospitnl...
Articles
Clin Sci Mol Med (1976) 51 (s3): 673s–675s.
Published: 01 December 1976
... mortality was far higher in men than in women. 4. Causes of death were stroke in 17%, heart failure in 24%, coronary occlusion in 16%, uraemia in 4% and other diseases in 39%. At the first examination thirteen cases of malignant hypertension were registered, none at later sessions. © 1976 The Biochemical...
Articles
Clin Sci Mol Med (1973) 45 (s1): 67s–70s.
Published: 01 August 1973
... and the Medical Research Society 1994 multi-centre randomized morbidity mortality myocardial infarct blood pressure measurement population screening drug treatment Clinical Science and Molecular Medicine (1973) 45,67s-70~. THE ORGANIZATION OF A MULTI-CENTRE RANDOMIZED CONTROL THERAPEUTIC TRIAL...